Authors

Cruise the River of Kings in Bangkok

Face the Facts and Find Investor Peace

MUSC Pilot Program Shows Success in Treating Opioid Users

Research demonstrates that medication-assisted treatment for opioid addiction works, yet few have adopted it.

Are statins cardioprotective in patients undergoing major vascular surgery?

We evaluated the cardioprotective effects of intensive statin therapy before major vascular surgery in a prospective study of 359 subjects. After multivariate analysis, lower low-density lipoprotein (LDL) cholesterol was associated with decreased myocardial ischemia, troponin T release, and 30-day and late cardiac events. Furthermore, higher doses of statins were associated with better cardiac outcome, even after adjusting for LDL cholesterol.

Radiofrequency ablation vs medical therapy after a first episode of symptomatic atrial flutter

Atrial flutter is an arrhythmia that occurs less commonly than atrial fibrillation and is often resistant to rate control and termination.

Maximize Your Digital Front Door During COVID-19

A look at the available and viable tools to continue patient access and care.

Take An Expert Approach to Retirement

Lipoprotein(a) and coronary artery disease:

The well-established causative role of low-density lipoprotein particles in atherosclerotic plaque development has led to this biomarker being a primary target of treatment in the prevention of coronary artery disease.

Roshni Patel, BSc, MCOptom: The State of Glaucoma in 2020

An optometrist from Europe discusses the current state of glaucoma from identification to treatment.

NDA for NTM Lung Disease Treatment Submitted to FDA

Insmed Incorporated announced that it has submitted its New Drug Application for amikacin liposome inhalation suspension (ALIS) to the U.S. FDA.

Patent foramen ovale closure for stroke prevention: A myriad of unanswered questions

Migraines, including those with aura, are common and generally benign, affecting between 10% and 15% of the population.

Avoid Costly IRA Planning Mistakes

Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia

The effects of recurrent tachycardia after resolution of cardiomyopathy have not been thoroughly assessed. We evaluated and followed 24 patients with tachycardia-induced cardiomyopathy for more than 12 years. Our observations showed that patients with tachycardia-induced cardiomyopathy may be at long-term risk for sudden death. Surreptitious cardiomyopathy due to occult ultrastructural changes may persist. It has yet to be determined whether rapid and aggressive rate control would prevent structural damage to risk of sudden cardiac death.